AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
AAPL   319.35 (+0.24%)
MSFT   182.82 (-0.38%)
FB   235.30 (+0.17%)
GOOGL   1,434.37 (+1.50%)
AMZN   2,434.29 (-0.11%)
NVDA   350.84 (-2.76%)
BABA   202.82 (+1.56%)
MU   46.58 (+3.65%)
GE   6.88 (+7.17%)
TSLA   819.21 (+0.29%)
AMD   54.22 (-1.72%)
T   31.06 (+3.95%)
ACB   15.89 (-0.75%)
GILD   74.18 (+1.15%)
DIS   122.10 (+3.46%)
BAC   24.36 (+7.50%)
BA   145.58 (+5.85%)
Log in

NASDAQ:NYMXNymox Pharmaceutical News Headlines

$3.41
-0.04 (-1.16 %)
(As of 05/26/2020 02:24 PM ET)
Add
Compare
Today's Range
$3.31
Now: $3.41
$3.48
50-Day Range
$2.10
MA: $2.77
$3.45
52-Week Range
$1.32
Now: $3.41
$4.09
Volume6,052 shs
Average Volume126,061 shs
Market Capitalization$242.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.71

Headlines

Nymox Pharmaceutical (NASDAQ NYMX) News Headlines

Source:
DateHeadline
Nymox Pharmaceutical Corp (NASDAQ:NYMX) Short Interest Up 7.9% in MayNymox Pharmaceutical Corp (NASDAQ:NYMX) Short Interest Up 7.9% in May
www.americanbankingnews.com - May 21 at 9:41 PM
If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago Youd Have Made 91%If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91%
finance.yahoo.com - May 5 at 9:39 AM
If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91%If You Had Bought Nymox Pharmaceutical (NASDAQ:NYMX) Shares Five Years Ago You'd Have Made 91%
finance.yahoo.com - May 5 at 9:39 AM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Nymox Pharmaceutical Corporation (NYMX)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Nymox Pharmaceutical Corporation (NYMX)
www.bloomberg.com - April 25 at 10:36 PM
Nymox Announces Important New Patent DevelopmentsNymox Announces Important New Patent Developments
finance.yahoo.com - April 21 at 11:08 AM
Is Nymox Pharmaceutical (NASDAQ:NYMX) In A Good Position To Deliver On Growth Plans?Is Nymox Pharmaceutical (NASDAQ:NYMX) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - March 21 at 10:42 AM
Nymox Announces New Peer Review Publication of Prostate Cancer Fexapotide Clinical Trial Results in World Journal of UrologyNymox Announces New Peer Review Publication of Prostate Cancer Fexapotide Clinical Trial Results in World Journal of Urology
finance.yahoo.com - February 24 at 9:35 AM
Nymox Pharmaceutical: Employee Resume Substantiates ConcernsNymox Pharmaceutical: Employee Resume Substantiates Concerns
seekingalpha.com - February 20 at 3:04 PM
Nymox Pharmaceuticals Has A Long History Of Broken Promises And Baffling Delays That Will Likely ContinueNymox Pharmaceuticals Has A Long History Of Broken Promises And Baffling Delays That Will Likely Continue
seekingalpha.com - February 6 at 12:39 PM
Nymox Announces New Appointment of Russell Thomson Ph.D. as Nymox Vice President of Quality and Regulatory AffairsNymox Announces New Appointment of Russell Thomson Ph.D. as Nymox Vice President of Quality and Regulatory Affairs
finance.yahoo.com - February 6 at 12:39 PM
Is Nymox Pharmaceutical Corporations (NASDAQ:NYMX) CEO Being Overpaid?Is Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) CEO Being Overpaid?
finance.yahoo.com - February 5 at 7:31 PM
Is Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) CEO Being Overpaid?Is Nymox Pharmaceutical Corporation's (NASDAQ:NYMX) CEO Being Overpaid?
finance.yahoo.com - February 5 at 2:31 PM
Nymox Provides Update on Current Corporate Activities and MilestonesNymox Provides Update on Current Corporate Activities and Milestones
finance.yahoo.com - January 28 at 12:56 PM
Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Reports in UrologyNymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Reports in Urology
finance.yahoo.com - January 6 at 5:05 PM
Hedge Funds Have Never Been More Bullish On Nymox Pharmaceutical Corporation (NYMX)Hedge Funds Have Never Been More Bullish On Nymox Pharmaceutical Corporation (NYMX)
finance.yahoo.com - December 23 at 6:23 PM
Nymox Pharmaceutical Corporation (NASDAQ:NYMX): What Does Its Beta Value Mean For Your Portfolio?Nymox Pharmaceutical Corporation (NASDAQ:NYMX): What Does Its Beta Value Mean For Your Portfolio?
finance.yahoo.com - December 20 at 8:18 AM
Is Kala Pharmaceuticals, Inc. (KALA) A Good Stock To Buy?Is Kala Pharmaceuticals, Inc. (KALA) A Good Stock To Buy?
finance.yahoo.com - December 19 at 11:40 PM
The Nymox Pharmaceutical (NASDAQ:NYMX) Share Price Is Up 172% And Shareholders Are Boasting About ItThe Nymox Pharmaceutical (NASDAQ:NYMX) Share Price Is Up 172% And Shareholders Are Boasting About It
finance.yahoo.com - November 5 at 1:40 PM
Nymox Pharmaceutical Corp.Nymox Pharmaceutical Corp.
www.barrons.com - November 2 at 12:10 AM
Nymox Pharmaceuticals (NYMX) Stock Spikes Today on Prostate Cancer Trial DataNymox Pharmaceuticals (NYMX) Stock Spikes Today on Prostate Cancer Trial Data
www.thestreet.com - November 2 at 12:10 AM
Nymox Pharmaceutical CorpNymox Pharmaceutical Corp
www.reuters.com - October 24 at 11:35 PM
Nymox Reports on Newly Issued Patents and Corporate DevelopmentsNymox Reports on Newly Issued Patents and Corporate Developments
finance.yahoo.com - October 21 at 1:05 PM
Nymox Reports on Newly Issued Patents and Corporate DevelopmentsNymox Reports on Newly Issued Patents and Corporate Developments
feeds.benzinga.com - October 21 at 10:33 AM
6 Stocks to Buy Based on Insider Buying6 Stocks to Buy Based on Insider Buying
investorplace.com - July 8 at 12:21 PM
Wednesday 7/3 Insider Buying Report: PLAY, NYMXWednesday 7/3 Insider Buying Report: PLAY, NYMX
www.marketwatch.com - July 3 at 5:33 PM
Nymox End of Q2 New Investor Presentation on WebsiteNymox End of Q2 New Investor Presentation on Website
feeds.benzinga.com - June 25 at 12:48 PM
What Kind Of Investor Owns Most Of Nymox Pharmaceutical Corporation (NASDAQ:NYMX)?What Kind Of Investor Owns Most Of Nymox Pharmaceutical Corporation (NASDAQ:NYMX)?
finance.yahoo.com - June 18 at 5:47 PM
Nymox Pharmaceutical: Assessing The Short And Long IdeasNymox Pharmaceutical: Assessing The Short And Long Ideas
seekingalpha.com - June 14 at 10:02 AM
Before You Buy Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Consider Its VolatilityBefore You Buy Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Consider Its Volatility
finance.yahoo.com - May 10 at 5:53 PM
Nymox Reports Pre-NDA CMC Meeting with the FDANymox Reports Pre-NDA CMC Meeting with the FDA
finance.yahoo.com - April 16 at 6:17 PM
Nymox Teleconference Monday, March 25 10:00 a.m. EDTNymox Teleconference Monday, March 25 10:00 a.m. EDT
finance.yahoo.com - March 21 at 6:18 PM
Nymox Announces Appointment of Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls (CMC) Nymox Announces Appointment of Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls (CMC) 
finance.yahoo.com - March 19 at 6:26 PM
Nymox Announces Appointment of Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls (CMC)Nymox Announces Appointment of Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls (CMC)
www.globenewswire.com - March 19 at 9:51 AM
Introducing Nymox Pharmaceutical (NASDAQ:NYMX), The Stock That Slid 60% In The Last Five YearsIntroducing Nymox Pharmaceutical (NASDAQ:NYMX), The Stock That Slid 60% In The Last Five Years
finance.yahoo.com - March 18 at 6:32 PM
Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Companys Manufacturing Operations - GlobeNewswireNymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations - GlobeNewswire
globenewswire.com - March 15 at 9:57 AM
Nymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Companys Manufacturing OperationsNymox Announces Appointment of Russell Thomson Ph.D. as Director of Quality and EU Qualified Person for Company's Manufacturing Operations
finance.yahoo.com - March 13 at 5:55 PM
Nymox to Host Investor TeleconferenceNymox to Host Investor Teleconference
finance.yahoo.com - March 11 at 6:31 PM
Does The Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Share Price Fall With The Market?Does The Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Share Price Fall With The Market?
finance.yahoo.com - January 30 at 5:47 PM
New Peer Review Article Entitled “Efficacy and safety of fexapotide triflutate in outpatient medical treatment ...New Peer Review Article Entitled “Efficacy and safety of fexapotide triflutate in outpatient medical treatment ...
globenewswire.com - January 15 at 5:15 PM
New Peer Review Article Entitled “Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia” Published in Therapeutic Advances in UrologyNew Peer Review Article Entitled “Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia” Published in Therapeutic Advances in Urology
finance.yahoo.com - January 15 at 5:15 PM
2018: A Year of Achievements for NYMOX2018: A Year of Achievements for NYMOX
finance.yahoo.com - December 19 at 4:54 PM
Are Insiders Selling Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Stock?Are Insiders Selling Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Stock?
finance.yahoo.com - December 14 at 4:49 PM
This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.